This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (80)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Bioterrorism  • Review  • Alert me on articles by topic

James C. Pile, MD; John D. Malone, MD; Edward M. Eitzen, MD, MPH; Arthur M. Friedlander, MD

Arch Intern Med. 1998;158:429-434.

Anthrax is a zoonotic illness recognized since antiquity. Today, human anthrax has been all but eradicated from the industrialized world, with the vast majority of practitioners in the United States unlikely to have seen a case. Unfortunately, the disease remains endemic in many areas of the world, and anthrax poses a threat as a mass casualty–producing weapon if used in a biological warfare capacity.

From the Infectious Diseases Division, National Naval Medical Center, Bethesda, Md (Drs Pile and Malone), and the US Army Medical Research Institute of Infectious Diseases, Frederick, Md (Drs Eitzen and Friedlander).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of Oritavancin in a Murine Model of Bacillus anthracis Spore Inhalation Anthrax
Heine et al.
Antimicrob. Agents Chemother. 2008;52:3350-3357.
ABSTRACT | FULL TEXT  

Modeling the Incubation Period of Inhalational Anthrax
Wilkening
Med Decis Making 2008;28:593-605.
ABSTRACT  

Behavior of Bacillus anthracis Strains Sterne and Ames K0610 in Sterile Raw Ground Beef
Tamplin et al.
Appl. Environ. Microbiol. 2008;74:1111-1116.
ABSTRACT | FULL TEXT  

Pharmacokinetics-Pharmacodynamics of Gatifloxacin in a Lethal Murine Bacillus anthracis Inhalation Infection Model
Ambrose et al.
Antimicrob. Agents Chemother. 2007;51:4351-4355.
ABSTRACT | FULL TEXT  

Determination of Antibiotic Efficacy against Bacillus anthracis in a Mouse Aerosol Challenge Model
Heine et al.
Antimicrob. Agents Chemother. 2007;51:1373-1379.
ABSTRACT | FULL TEXT  

Sverdlovsk revisited: Modeling human inhalation anthrax
Wilkening
Proc. Natl. Acad. Sci. USA 2006;103:7589-7594.
ABSTRACT | FULL TEXT  

Systematic review: a century of inhalational anthrax cases from 1900 to 2005.
Holty et al.
ANN INTERN MED 2006;144:270-280.
ABSTRACT | FULL TEXT  

Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice
Brook et al.
J Antimicrob Chemother 2005;56:1074-1080.
ABSTRACT | FULL TEXT  

Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without 60Co gamma-photon irradiation
Brook et al.
J Med Microbiol 2005;54:1157-1162.
ABSTRACT | FULL TEXT  

Rabbit and Nonhuman Primate Models of Toxin-Targeting Human Anthrax Vaccines
Phipps et al.
Microbiol. Mol. Biol. Rev. 2004;68:617-629.
ABSTRACT | FULL TEXT  

One hundred years of anthrax
Nicoll and Maynard
Occup. Environ. Med. 2004;61:95-95.
FULL TEXT  

Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak
Brookmeyer et al.
Proc. Natl. Acad. Sci. USA 2003;100:10129-10132.
ABSTRACT | FULL TEXT  

Antimicrobial Therapy for Bacillus anthracis-Induced Polymicrobial Infection in 60Co {gamma}-Irradiated Mice
Elliott et al.
Antimicrob. Agents Chemother. 2002;46:3463-3471.
ABSTRACT | FULL TEXT  

Anthrax as a Biological Weapon: An Old Disease That Poses a New Threat
Tasota et al.
Crit Care Nurse 2002;22:21-34.
FULL TEXT  

Chemical and biological weapons. Implications for anaesthesia and intensive care{dagger}
White
Br J Anaesth 2002;89:306-324.
ABSTRACT | FULL TEXT  

Antimicrobial Susceptibility Testing of Bacillus anthracis: Comparison of Results Obtained by Using the National Committee for Clinical Laboratory Standards Broth Microdilution Reference and Etest Agar Gradient Diffusion Methods
Mohammed et al.
J. Clin. Microbiol. 2002;40:1902-1907.
ABSTRACT | FULL TEXT  

Anthrax as a Biological Weapon, 2002: Updated Recommendations for Management
Inglesby et al.
JAMA 2002;287:2236-2252.
ABSTRACT | FULL TEXT  

Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women
Wiesen and Littell
JAMA 2002;287:1556-1560.
ABSTRACT | FULL TEXT  

Recognition and Management of Anthrax
McGovern et al.
NEJM 2002;346:943-945.
FULL TEXT  

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Mina et al.
JAMA 2002;287:858-862.
ABSTRACT | FULL TEXT  

Clinical Presentation of Inhalational Anthrax Following Bioterrorism Exposure: Report of 2 Surviving Patients
Mayer et al.
JAMA 2001;286:2549-2553.
ABSTRACT | FULL TEXT  

Anthrax: of bison and bioterrorism
Weir
CMAJ 2000;163:608-608.
FULL TEXT  

In Vitro Development of Resistance to Ofloxacin and Doxycycline in Bacillus anthracis Sterne
Choe et al.
Antimicrob. Agents Chemother. 2000;44:1766-1766.
FULL TEXT  

Chemical-Biological Terrorism and Its Impact on Children: A Subject Review
Committee on Environmental Health and Committee on
Pediatrics 2000;105:662-670.
ABSTRACT | FULL TEXT  

Inhalational Anthrax: Epidemiology, Diagnosis, and Management
Shafazand et al.
Chest 1999;116:1369-1376.
ABSTRACT | FULL TEXT  

Anthrax as a Biological Weapon: Medical and Public Health Management
Inglesby et al.
JAMA 1999;281:1735-1745.
ABSTRACT | FULL TEXT  

Bioterrorism Alleging Use of Anthrax and Interim Guidelines for Management--United States, 1998
JAMA 1999;281:787-789.
FULL TEXT  

Anthrax: A Potential Biological Weapon
JWatch Emergency Med. 1998;1998:7-7.
FULL TEXT  

Inhalational Anthrax after Bioterrorism Exposure: Spectrum of Imaging Findings in Two Surviving Patients
Earls et al.
Radiology 2002;222:305-312.
ABSTRACT | FULL TEXT